冠脉介入治疗-话题@MedSci

#冠脉介入治疗#

17篇内容 | 819人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1443551, encodeId=76b31443551cb, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=Eur Heart J：缺血性心力衰竭患者采用冠脉旁路移植术治疗的长期死亡率明显低于经皮冠脉介入治疗！, objectType=article, longId=212273, objectId=f9a52122e3bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9a52122e3bf, replyNumber=0, likeNumber=27, createdTime=2021-06-05, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9a52122e3bf, moduleTitle=Eur Heart J：缺血性心力衰竭患者采用冠脉旁路移植术治疗的长期死亡率明显低于经皮冠脉介入治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9a52122e3bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443550, encodeId=2b0c14435503e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=Lancet：经皮冠脉介入治疗后需无限期抗血小板治疗的患者请注意，氯吡格雷单药疗法优于阿司匹林！, objectType=article, longId=211547, objectId=899121154ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=899121154ea2, replyNumber=0, likeNumber=26, createdTime=2021-05-21, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=899121154ea2, moduleTitle=Lancet：经皮冠脉介入治疗后需无限期抗血小板治疗的患者请注意，氯吡格雷单药疗法优于阿司匹林！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=899121154ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443549, encodeId=5dde144354954, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=以简御繁——复杂冠脉介入治疗后的调脂治疗, objectType=article, longId=202986, objectId=1fdf20298614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fdf20298614, replyNumber=0, likeNumber=45, createdTime=2020-11-08, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fdf20298614, moduleTitle=以简御繁——复杂冠脉介入治疗后的调脂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fdf20298614)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443548, encodeId=07701443548ba, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗, objectType=article, longId=196596, objectId=cd881965961c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd881965961c, replyNumber=0, likeNumber=30, createdTime=2020-06-29, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd881965961c, moduleTitle=Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd881965961c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443547, encodeId=6841144354e79, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=女士冠脉介入治疗效果不如男士！JACC汇总分析21项随机研究, objectType=article, longId=192038, objectId=f04c1920383f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f04c1920383f, replyNumber=0, likeNumber=39, createdTime=2020-04-13, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f04c1920383f, moduleTitle=女士冠脉介入治疗效果不如男士！JACC汇总分析21项随机研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f04c1920383f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443546, encodeId=419014435466f, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=2019 全球专家共识：慢性完全闭塞病变经皮冠脉介入治疗的指导原则, objectType=article, longId=176664, objectId=d98f1e6664ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d98f1e6664ca, replyNumber=0, likeNumber=21, createdTime=2019-08-03, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d98f1e6664ca, moduleTitle=2019 全球专家共识：慢性完全闭塞病变经皮冠脉介入治疗的指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d98f1e6664ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443545, encodeId=6e5c1443545e3, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=阜外医院经验：女性冠脉介入治疗选经桡动脉路径更安全，可显著降低严重出血和穿刺点并发症, objectType=article, longId=152149, objectId=9c5915214967, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c5915214967, replyNumber=0, likeNumber=33, createdTime=2018-10-30, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c5915214967, moduleTitle=阜外医院经验：女性冠脉介入治疗选经桡动脉路径更安全，可显著降低严重出血和穿刺点并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c5915214967)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443544, encodeId=4d0d1443544b6, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局, objectType=article, longId=135517, objectId=1c0113551ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0113551ea6, replyNumber=0, likeNumber=43, createdTime=2018-04-18, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0113551ea6, moduleTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0113551ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443543, encodeId=d9831443543b1, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后的30天再入院率及费用, objectType=article, longId=124197, objectId=834912419e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=834912419e42, replyNumber=0, likeNumber=40, createdTime=2017-12-23, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=834912419e42, moduleTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后的30天再入院率及费用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=834912419e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443542, encodeId=92241443542d3, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=建立冠脉介入治疗质量控制体系助力学科发展, objectType=article, longId=119913, objectId=c5b911991312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5b911991312, replyNumber=0, likeNumber=35, createdTime=2017-11-15, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5b911991312, moduleTitle=建立冠脉介入治疗质量控制体系助力学科发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5b911991312)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443541, encodeId=0447144354111, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=湘雅公卫学者Meta分析：对于接受冠脉介入治疗的患者，替格瑞洛能否替代氯吡格雷？, objectType=article, longId=117827, objectId=0aaf11e8277d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aaf11e8277d, replyNumber=0, likeNumber=0, createdTime=2017-10-28, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aaf11e8277d, moduleTitle=湘雅公卫学者Meta分析：对于接受冠脉介入治疗的患者，替格瑞洛能否替代氯吡格雷？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aaf11e8277d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443540, encodeId=f06214435405e, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=JACC：经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗, objectType=article, longId=108853, objectId=024a108853ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=024a108853ff, replyNumber=0, likeNumber=31, createdTime=2017-08-17, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=024a108853ff, moduleTitle=JACC：经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=024a108853ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443539, encodeId=ca3b14435395b, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=JACC：体质量指数与经皮冠脉介入治疗结果的关系, objectType=article, longId=104521, objectId=01ee104521ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01ee104521ac, replyNumber=0, likeNumber=41, createdTime=2017-07-06, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01ee104521ac, moduleTitle=JACC：体质量指数与经皮冠脉介入治疗结果的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01ee104521ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443538, encodeId=63c1144353825, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=JACC：经皮冠脉介入治疗支架内完全闭塞的疗效观察, objectType=article, longId=98166, objectId=495b9816604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495b9816604, replyNumber=0, likeNumber=34, createdTime=2017-05-10, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495b9816604, moduleTitle=JACC：经皮冠脉介入治疗支架内完全闭塞的疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=495b9816604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443537, encodeId=3cde144353e0c, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=CCI:替卡格雷与普拉格雷对接受冠脉介入治疗的非ST段抬高心梗患者的影响, objectType=article, longId=20919, objectId=255e2091949, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=255e2091949, replyNumber=0, likeNumber=41, createdTime=2013-07-06, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=255e2091949, moduleTitle=CCI:替卡格雷与普拉格雷对接受冠脉介入治疗的非ST段抬高心梗患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=255e2091949)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443536, encodeId=7b0d1443536a1, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=经前臂动脉冠脉介入治疗研究进展及展望, objectType=article, longId=17804, objectId=8fba1e8043d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fba1e8043d, replyNumber=0, likeNumber=30, createdTime=2013-04-29, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fba1e8043d, moduleTitle=经前臂动脉冠脉介入治疗研究进展及展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fba1e8043d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1443535, encodeId=a6c1144353579, content=<a href='/topic/show?id=1ed0309444e' target=_blank style='color:#2F92EE;'>#冠脉介入治疗#</a>, objectTitle=经皮冠脉介入治疗中对比剂肾病的预防, objectType=article, longId=6708, objectId=970f6e08d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=970f6e08d7, replyNumber=0, likeNumber=50, createdTime=2012-05-31, rootId=0, userName=12498ebem20暂无昵称, userId=f44f5082140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=970f6e08d7, moduleTitle=经皮冠脉介入治疗中对比剂肾病的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=970f6e08d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

Eur Heart J：缺血性心力衰竭患者采用冠脉旁路移植术治疗的长期死亡率明显低于经皮冠脉介入治疗！

2021-06-05

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

Lancet：经皮冠脉介入治疗后需无限期抗血小板治疗的患者请注意，氯吡格雷单药疗法优于阿司匹林！

2021-05-21

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

以简御繁——复杂冠脉介入治疗后的调脂治疗

2020-11-08

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗

2020-06-29

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

女士冠脉介入治疗效果不如男士！JACC汇总分析21项随机研究

2020-04-13

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

2019 全球专家共识：慢性完全闭塞病变经皮冠脉介入治疗的指导原则

2019-08-03

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

阜外医院经验：女性冠脉介入治疗选经桡动脉路径更安全，可显著降低严重出血和穿刺点并发症

2018-10-30

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局

2018-04-18

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

Circ: Cardiovasc Inte：经皮冠脉介入治疗后的30天再入院率及费用

2017-12-23

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

建立冠脉介入治疗质量控制体系助力学科发展

2017-11-15

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

湘雅公卫学者Meta分析：对于接受冠脉介入治疗的患者，替格瑞洛能否替代氯吡格雷？

2017-10-28

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

JACC：经同侧旁路通道的逆向慢性完全闭塞经皮冠脉介入治疗

2017-08-17

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

JACC：体质量指数与经皮冠脉介入治疗结果的关系

2017-07-06

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

JACC：经皮冠脉介入治疗支架内完全闭塞的疗效观察

2017-05-10

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

CCI:替卡格雷与普拉格雷对接受冠脉介入治疗的非ST段抬高心梗患者的影响

2013-07-06

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

经前臂动脉冠脉介入治疗研究进展及展望

2013-04-29

12498ebem20暂无昵称 (审核中...)

前往app查看评论内容

#冠脉介入治疗#

经皮冠脉介入治疗中对比剂肾病的预防

2012-05-31

科室
- - 订阅+
  - 更多科室
工具
服务